Literature DB >> 30341894

Circular RNA in cardiovascular disease.

M-Ashraf Altesha1, Tiffany Ni2, Afaan Khan3, Kexiang Liu4, Xiufen Zheng1,5,6,7,8.   

Abstract

Circular RNA (circRNA) are endogenous transcripts that display differential expression across species, developmental stages, and pathologies. Their lack of free ends confers increased stability when compared with linear transcripts, making them ideal candidates for future diagnostic biomarkers and therapeutic interventions. Increasing evidence has implicated circRNA in the pathogenesis of multiple cardiovascular diseases. In this paper, we summarize current understanding of circRNA biogenesis, properties, expression profiles, detection methods, functions, and their implication in cardiac pathologies including/ischemia reperfusion injury, myocardial infarction, cardiac senescence, cardiac fibrosis, cardiomyopathy, cardiac hypertrophy and heart failure, atherosclerosis, coronary artery disease, and aneurysm.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  biogenesis; cardiovascular disease; circular RNA; miRNA sponge

Mesh:

Substances:

Year:  2018        PMID: 30341894     DOI: 10.1002/jcp.27384

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  129 in total

Review 1.  Circular RNAs in Immune Response and Viral Infection.

Authors:  Lichong Yan; Y Grace Chen
Journal:  Trends Biochem Sci       Date:  2020-09-06       Impact factor: 13.807

2.  Differential expression and bioinformatic analysis of circRNA in nonalcoholic steatohepatitis cirrhosis.

Authors:  Yuexin Fan; Yang Zheng; Jiahui Wang; Tiejian Zhao; Tianjian Liang
Journal:  Int J Clin Exp Pathol       Date:  2020-11-01

3.  Astragaloside IV alleviates atherosclerosis through targeting circ_0000231/miR-135a-5p/CLIC4 axis in AS cell model in vitro.

Authors:  Xiao Shao; Zhaozheng Liu; Shanshan Liu; Na Lin; Yue Deng
Journal:  Mol Cell Biochem       Date:  2021-01-13       Impact factor: 3.396

4.  Circ_USP36/miR-182-5p/KLF5 axis regulates the ox-LDL-induced injury in human umbilical vein smooth muscle cells.

Authors:  Qiang Zhao; Ying-Hong Lu; Xin Wang; Xue-Jun Zhang
Journal:  Am J Transl Res       Date:  2020-12-15       Impact factor: 4.060

Review 5.  The Function and Therapeutic Potential of Circular RNA in Cardiovascular Diseases.

Authors:  Kai Wang; Xiang-Qian Gao; Tao Wang; Lu-Yu Zhou
Journal:  Cardiovasc Drugs Ther       Date:  2021-07-16       Impact factor: 3.727

6.  Genome-wide analysis of circular RNAs involved in Marek's disease tumourigenesis in chickens.

Authors:  Lulu Wang; Zhen You; Mingyue Wang; Yiming Yuan; Changjun Liu; Ning Yang; Hao Zhang; Ling Lian
Journal:  RNA Biol       Date:  2020-01-17       Impact factor: 4.652

Review 7.  Circular RNAs: Novel target of diabetic retinopathy.

Authors:  Huan-Ran Zhou; Hong-Yu Kuang
Journal:  Rev Endocr Metab Disord       Date:  2021-03-24       Impact factor: 6.514

Review 8.  Circular RNAs in kidney disease and cancer.

Authors:  Anton Jan van Zonneveld; Malte Kölling; Roel Bijkerk; Johan M Lorenzen
Journal:  Nat Rev Nephrol       Date:  2021-08-11       Impact factor: 28.314

Review 9.  Regulation of Nrf2 signaling pathway in heart failure: Role of extracellular vesicles and non-coding RNAs.

Authors:  Changhai Tian; Lie Gao; Irving H Zucker
Journal:  Free Radic Biol Med       Date:  2021-03-17       Impact factor: 7.376

Review 10.  [Research advance of ANRIL on atherosclerosis by regulating cell proliferation and apoptosis].

Authors:  Juan Fang; Zhicheng Pan; Xiaogang Guo
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2020-05-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.